The French healthcare inspection agency, Agence Nationale de Sécurité du Médicament (ANSM), has issued an injunction against Stallergenes Greer after an inspection of its factory in Antony, Nordea writes in an analysis.
According to the Nordic bank, the authorities inspected the factory in February and found significant shortcomings.
Nordea assesses that Stallergenes will avoid the factory being shut down, but that this prediction is not entirely certain.
Back in 2015, Stallergenes Greer received another injunction regarding the same factory, which led to a long production halt and large-scale product recalls.
ALK generated extra sales in the French market during that period.
ALK expects to have approved peanut allergy vaccine in 2030
ALK to start phase I trial of peanut allergy tablet vaccine
Stallergenes bets big on personalized allergy treatment, enters another research collaboration
More from MedWatch
ALK to exit Turkish market: "It's bad business if all we get is peanuts"
A number of conditions made it unfeasible for the Danish allergy firm to do business in Türkiye, says CEO Carsten Hellmann. Under a calculated and ruthless strategy to focus on markets with momentum, efforts in Italy and Spain have also been reduced.
Genmab postpones crucial cancer candidate decision following Abbvie exit
For the rest of 2022, the Danish biotech firm will share all expenses relating to the development of Duohexabody-CD37 with Abbvie, despite the US-based firm’s decision to withdraw from the collaboration in question.
Genmab says new arbitration builds on a straightforward question
”I think this is a much simpler case than the first arbitration,” says Genmab CEO Jan van de Winkel on the new legal suit brought against Janssen, which stems from a fight Genmab has already lost once.
Top news from MedWatch this week
Miss anything?
Analyst: Upgraded ALK sales guidance could still be beaten
Despite an upgrade, ALK may still beat its own sales guidance, one Sydbank analyst predicts.
Clinical Project Leader/ Sr. Clinical Trial Manager – make a difference and join our mission to bring our IL-22 lead program to patients 
Biomarker Operations Lead 
GMP Compliance Consultant for Eltronic in Ballerup 
Senior Electronics Engineer 
Lead Auditor – Senior Quality Assurance Specialist 
Clinical Project/Trial Manager, Synklino 
Medical Scientific Communications Manager 
Senior Manager, QA GCP/PV 
Experienced Biostatistician 
Global Quality Director (Business Unit Quality Lead) 
Director Regulatory Affairs 
Scientist Radiochemistry